Advaxis, Inc. ADXS Company Overview
Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt1=Go!
Advaxis, Inc. ADXS Current Price and Quotes
Last Price 5.14
Previous Close 5.60 Open 5.60
Daily Range 5.61 - 5.05 52wk Range 19.38 - 2.60
Volume 75,678 Dividend N/A
Average Vol (3m) 35,721 Yield N/A
Advaxis, Inc. ADXS
Company Information
305 College Road East
Princeton, NJ 08540
Website: http://www.advaxis.com
Phone: 609-452-9813
Email: ir@advaxis.com
Find us on:
Advaxis, Inc. ADXS
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete an antigen/adjuvant fusion protein(s) that is designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself.
ADXS-HPV is currently being evaluated in four clinical trials for hum...
Advaxis, Inc. ADXS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 31, 2013 10-Q
CIK 0001100397
Fiscal Year End 10/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 01, 2012
Incorporated In: DE, USA
Year of Inc. 2002
Employees 12 a/o Mar 15, 2013
Company Officers/Contacts
Thomas Moore CEO
Daniel O'Connor EVP
Mark Rosenblum Senior VP, CFO, Secretary
Robert Petit Chief Scientific Officer
Company Directors
Thomas Moore Chairman
Ronie A. Appel
Richard Berman
Thomas McKearn
James Patton
David Sidransky
Company Notes
Note=1-31-05 company is in the development stage
Service Providers
Auditor/Accountant
Marcum LLP
750 Third Ave
New York, NY, 10017
United States
Legal Counsel
Not Available
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Atlanta, GA, 30344
United States
Advaxis, Inc. ADXS
ADXS Security Details
Share Structure
Market Value1 $28,134,854 a/o Sep 30, 2013
Shares Outstanding 5,024,081 a/o Sep 06, 2013
Float Not Available
Authorized Shares 25,000,000 a/o Jul 15, 2013
Par Value Not Available
Shareholders
Shareholders of Record 93 a/o Feb 13, 2013
Security Notes
Capital Change=shs decreased by 1 for 125 split. Ex-date=07/15/2013.
Short Selling Data
Short Interest 6,198 (245.29%)
Sep 13, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Securities Transfer Corp
Advaxis, Inc. ADXS Recent News
Sept 12, 2013 FNMA, WTER, ADXS and FMCC added to OTC Active Stock Watch List at EPR
Sept 12, 2013 OTC Signal Daily Stock Watch - Advaxis, Inc. (OTCQB: ADXS)
Sept 5, 2013 Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
Sept 3, 2013 Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting
Aug 20, 2013 Advaxis Appoints Daniel J. O'Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Aug 14, 2013 Advaxis' ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer
Aug 7, 2013 OTC Daily Alert Stock Watch - Advaxis, Inc. (OTCQB: ADXSD)
Jul 25, 2013 Advaxis Updates Business Outlook for 2013
Jul 17, 2013 Advaxis Announces ADXS-cHER2 Demonstrates Significant Survival Advantage in Ongoing Canine Osteosarcoma Study
Jul 16, 2013 Update on Advaxis Announces 1-for-125 Reverse Stock Split and Decrease in Authorized Shares of Common Stock
1
2
next >
Advaxis, Inc. ADXS Financials
Period Ending Oct 31, 2012 Oct 31, 2011 Oct 31, 2010 Oct 31, 2009
Total Revenue - - 508 30
Cost of Revenue - - - -
Gross Profit - - 508 30
Operating Expenses
Research and Development 6,646 8,079 4,904 2,316
Sales, General and Admin. 5,689 4,940 3,530 2,701
Non-Recurring Items - - - -
Other - - - -
Operating Income (12,335) (13,019) (7,926) (4,987)
Income From Continuing Operations
Add'l Income/Expense Items 4,455 9,223 650 5,845
Earnings Before Interest and Tax (7,880) (3,796) (7,276) 858
Interest Expense 4,537 4,699 3,815 851
Earnings Before Tax (12,416) (8,495) (11,091) 7
Income Tax (347) (379) (279) (922)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,070) (8,116) (10,688) 929
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,070) (8,116) (10,812) 929
Preferred Stock and Other Adjustments (740) (1,539) - -
Net Income Applicable to Common Shareholders (12,810) (9,654) (10,812) 929
ADXS Advaxis, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ADXS/quote
Stock Chart http://www.otcmarkets.com/stock/ADXS/chart
Company Info http://www.otcmarkets.com/stock/ADXS/company-info
Recent News http://www.otcmarkets.com/stock/ADXS/news
Financials http://www.otcmarkets.com/stock/ADXS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ADXS/filings
Short Sales http://www.otcmarkets.com/stock/ADXS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ADXS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ADXS/research
Summary http://finance.yahoo.com/q?s=ADXS
Historical Prices http://finance.yahoo.com/q/hp?s=ADXS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ADXS
Basic Chart http://finance.yahoo.com/q/bc?s=ADXS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ADXS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ADXS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ADXS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ADXS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ADXS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ADXS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ADXS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ADXS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ADXS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ADXS
Balance Sheet http://finance.yahoo.com/q/bs?s=ADXS
Cash Flow http://finance.yahoo.com/q/cf?s=ADXS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ADXS
Market Watch http://www.marketwatch.com/investing/stock/ADXS
Bloomberg http://www.bloomberg.com/quote/ADXS:US
Morningstar http://quotes.morningstar.com/stock/s?t=ADXS
Bussinessweek http://investing.businessweek.com/research/st...icker=ADXS
Barchart http://www.barchart.com/quotes/stocks/ADXS
OTC Short Report http://otcshortreport.com/index.php?index=ADXS
Investopedia http://www.investopedia.com/markets/stocks/ADXS/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt1=Go!
Advaxis, Inc. ADXS Current Price and Quotes
Last Price 5.14
Previous Close 5.60 Open 5.60
Daily Range 5.61 - 5.05 52wk Range 19.38 - 2.60
Volume 75,678 Dividend N/A
Average Vol (3m) 35,721 Yield N/A
Advaxis, Inc. ADXS
Company Information
305 College Road East
Princeton, NJ 08540
Website: http://www.advaxis.com
Phone: 609-452-9813
Email: ir@advaxis.com
Find us on:
Advaxis, Inc. ADXS
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete an antigen/adjuvant fusion protein(s) that is designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself.
ADXS-HPV is currently being evaluated in four clinical trials for hum...
Advaxis, Inc. ADXS
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jul 31, 2013 10-Q
CIK 0001100397
Fiscal Year End 10/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 01, 2012
Incorporated In: DE, USA
Year of Inc. 2002
Employees 12 a/o Mar 15, 2013
Company Officers/Contacts
Thomas Moore CEO
Daniel O'Connor EVP
Mark Rosenblum Senior VP, CFO, Secretary
Robert Petit Chief Scientific Officer
Company Directors
Thomas Moore Chairman
Ronie A. Appel
Richard Berman
Thomas McKearn
James Patton
David Sidransky
Company Notes
Note=1-31-05 company is in the development stage
Service Providers
Auditor/Accountant
Marcum LLP
750 Third Ave
New York, NY, 10017
United States
Legal Counsel
Not Available
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Atlanta, GA, 30344
United States
Advaxis, Inc. ADXS
ADXS Security Details
Share Structure
Market Value1 $28,134,854 a/o Sep 30, 2013
Shares Outstanding 5,024,081 a/o Sep 06, 2013
Float Not Available
Authorized Shares 25,000,000 a/o Jul 15, 2013
Par Value Not Available
Shareholders
Shareholders of Record 93 a/o Feb 13, 2013
Security Notes
Capital Change=shs decreased by 1 for 125 split. Ex-date=07/15/2013.
Short Selling Data
Short Interest 6,198 (245.29%)
Sep 13, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Securities Transfer Corp
Advaxis, Inc. ADXS Recent News
Sept 12, 2013 FNMA, WTER, ADXS and FMCC added to OTC Active Stock Watch List at EPR
Sept 12, 2013 OTC Signal Daily Stock Watch - Advaxis, Inc. (OTCQB: ADXS)
Sept 5, 2013 Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
Sept 3, 2013 Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting
Aug 20, 2013 Advaxis Appoints Daniel J. O'Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Aug 14, 2013 Advaxis' ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer
Aug 7, 2013 OTC Daily Alert Stock Watch - Advaxis, Inc. (OTCQB: ADXSD)
Jul 25, 2013 Advaxis Updates Business Outlook for 2013
Jul 17, 2013 Advaxis Announces ADXS-cHER2 Demonstrates Significant Survival Advantage in Ongoing Canine Osteosarcoma Study
Jul 16, 2013 Update on Advaxis Announces 1-for-125 Reverse Stock Split and Decrease in Authorized Shares of Common Stock
1
2
next >
Advaxis, Inc. ADXS Financials
Period Ending Oct 31, 2012 Oct 31, 2011 Oct 31, 2010 Oct 31, 2009
Total Revenue - - 508 30
Cost of Revenue - - - -
Gross Profit - - 508 30
Operating Expenses
Research and Development 6,646 8,079 4,904 2,316
Sales, General and Admin. 5,689 4,940 3,530 2,701
Non-Recurring Items - - - -
Other - - - -
Operating Income (12,335) (13,019) (7,926) (4,987)
Income From Continuing Operations
Add'l Income/Expense Items 4,455 9,223 650 5,845
Earnings Before Interest and Tax (7,880) (3,796) (7,276) 858
Interest Expense 4,537 4,699 3,815 851
Earnings Before Tax (12,416) (8,495) (11,091) 7
Income Tax (347) (379) (279) (922)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (12,070) (8,116) (10,688) 929
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (12,070) (8,116) (10,812) 929
Preferred Stock and Other Adjustments (740) (1,539) - -
Net Income Applicable to Common Shareholders (12,810) (9,654) (10,812) 929
ADXS Advaxis, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=ADXS&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ADXS/quote
Stock Chart http://www.otcmarkets.com/stock/ADXS/chart
Company Info http://www.otcmarkets.com/stock/ADXS/company-info
Recent News http://www.otcmarkets.com/stock/ADXS/news
Financials http://www.otcmarkets.com/stock/ADXS/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ADXS/filings
Short Sales http://www.otcmarkets.com/stock/ADXS/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ADXS/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ADXS/research
Summary http://finance.yahoo.com/q?s=ADXS
Historical Prices http://finance.yahoo.com/q/hp?s=ADXS+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ADXS
Basic Chart http://finance.yahoo.com/q/bc?s=ADXS+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ADXS+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ADXS+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ADXS+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ADXS+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ADXS+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ADXS+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ADXS+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ADXS+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ADXS+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ADXS
Balance Sheet http://finance.yahoo.com/q/bs?s=ADXS
Cash Flow http://finance.yahoo.com/q/cf?s=ADXS+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ADXS
Market Watch http://www.marketwatch.com/investing/stock/ADXS
Bloomberg http://www.bloomberg.com/quote/ADXS:US
Morningstar http://quotes.morningstar.com/stock/s?t=ADXS
Bussinessweek http://investing.businessweek.com/research/st...icker=ADXS
Barchart http://www.barchart.com/quotes/stocks/ADXS
OTC Short Report http://otcshortreport.com/index.php?index=ADXS
Investopedia http://www.investopedia.com/markets/stocks/ADXS/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
